| TSIA | total small intestine allotransplantation; triple sugar iron agar |
|---|---|
| TSU | triple sugar urea [agar] |
| TVC | timed vital capacity; total viable cells; total volume capacity; transvaginal cone; triple voiding c... |
| TVD | transmissible virus dementia; triple vessel disease |
| AAC | antibiotic-associated [pseudomembranous] colitis; antimicrobial agent-induced colitis; augmentative ... |
| antibiotic assay | <investigation> A test to determine how sensitive a bacterial or fungal strain is to arange of antibiotics bymeasuring the microbes' ability to grow in astandard dilution of each chemical. (09 Oct 1997) |
|---|---|
| antibiotic enterocolitis | Enterocolitis caused by oral administration of broad spectrum antibiotics, resulting from overgrowth of antibiotic-resistant staphylococci or yeasts and fungi, when the normal faecal Gram-negative organisms are suppressed, resulting in diarrhoea or pseudomembranous disease. (05 Mar 2000) |
| antibiotic eye drops | <pharmacology> A medication that is pH balanced to allow placement into the eye for the purpose of killing bacteria. Examples include: Bleph-10, Chloromycetin, Cortisporin-Ophthalmic, Gantrisin, Genoptic, Gentacidin, Garamycin, Gantrisin, Ilotycin, Sodium Sulamyd and Sulphair. (27 Sep 1997) |
| antibiotic induced enteritis | <pathology> A condition where the normal intestinal bacteria (useful for digestion) are killed by the use of an antibiotic resulting in symptoms. (27 Sep 1997) |
| antibiotic induced gastroenteritis | <pathology> A condition where the normal intestinal bacteria (useful for digestion) are killed by the use of an antibiotic resulting in symptoms. (27 Sep 1997) |
| antibiotic ointment | A ointment (or cream) based medication that kills bacteria. Examples include Neosporin, Bactroban, Garamycin, bacitracin, gentamicin, mupirocin, neomycin, silver sulphasalazine, chloramphenicol and clindamycin. (27 Sep 1997) |
| antibiotic prophylaxis | Use of antibiotics before, during, or after a diagnostic, therapeutic, or surgical procedure to prevent infectious complications. (12 Dec 1998) |
| antibiotic resistance | The ability of a bacterium tosynthesise a protein that neutralises an antibiotic. (09 Oct 1997) |
| antibiotic resistance gene | Genes in a microorganism which confer resistance to antibiotics, for example by coding for enzymes which destroy it, by coding for surface proteins which prevent it from entering the microorganism, or by being a mutant form of the antibiotic's target so that it can ignore it. (09 Oct 1997) |
| antibiotic-resistant | Indicating microorganisms that continue to multiply although exposed to antibiotic agents. (05 Mar 2000) |
| antibiotic sensitivity | Microbial susceptibility to antibiotics. See: antibiotic sensitivity test, minimal inhibitory concentration. (05 Mar 2000) |
| antibiotic sensitivity test | The in vitro testing of bacterial cultures with antibiotics to determine susceptibility of bacteria to antibiotic therapy. (05 Mar 2000) |
| broad spectrum antibiotic | An antibiotic having a wide range of activity against both Gram-positive and Gram-negative organisms. (05 Mar 2000) |
| resistance, antibiotic | The ability of bacteria and other microorganisms to withstand an antibiotic to which they were once sensitive (and were once stalled or killed outright). Also called drug resistance. (12 Dec 1998) |
| peptide antibiotic lactonase | <enzyme> Peptide lactone and water gives linear peptide Registry number: EC 3.1.1.- (26 Jun 1999) |